Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
公司代碼INBS
公司名稱Intelligent Bio Solutions Inc
上市日期Dec 23, 2020
CEOSimeonidis (Harry)
員工數量16
證券類型Ordinary Share
年結日Dec 23
公司地址135 W 41St St,
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編10036
電話16467905756
網址https://ibs.inc/
公司代碼INBS
上市日期Dec 23, 2020
CEOSimeonidis (Harry)